Minority participation in clinical trials is an important topic in public health discussions. This representation touches on issues of equality and the elimination of disparities, which are core values of the field. The FDA Safety and Innovation Act introduced in 2012,…
6 Reasons to Diversify Clinical Trials
Starting from the fact that minorities account for fewer than 10 percent of patients enrolled in clinical trials. Health disparities and underrepresentation in clinical trials could become a serious issue in the upcoming years. FDA Regulations In 2012 Congress included Section…
Psoriatic Arthritis Drug Shows Promise in Phase 3 Trial
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced a significant reduction in symptoms, including joint tenderness and swelling, when…
Clinical Trials Diversity – More Minorities Needed to Make Research Relevant to All
Minorities, in fact, account for fewer than 10 percent of patients enrolled in clinical trials, according to the National Institutes of Health (NIH) National Institute on Minority Health and Health Disparities. Today, Wilkins brings together academic researchers and community members to…
Clinical Research in Ecuador | Diversity in Hispanic Community Involvement
Why Is Diversity Important? FDA Action Plan In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic subgroups, including…
Landmark Clinical Trial to Help Juvenile Idiopathic Arthritis Sufferers
A clinical trial funded by Arthritis Research UK and the National Institute for Health Research (NIHR), led by professors from the Universities of Liverpool and Bristol, has discovered a drug combination that could help thousands of children with Juvenile Idiopathic Arthritis….
How to boost Hispanics’ participation in clinical trials? Relate to them, study shows
Hispanic cancer patients rarely participate in clinical trials, but researchers want to tailor a Spanish DVD to help change this. To create a relevant educational tool, Moffitt Cancer Center researchers investigated why awareness of and participation in trials are so low…
Turning Back the Aging Clock
Researchers from Caltech and UCLA have developed a new approach targeting Aging Mitochondrial DNA to remove cellular damage that accumulates with age. Led by Nikolay Kandul, senior postdoctoral scholar in biology and biological engineering in the laboratory of Professor of Biology…
Minority Inclusion in Clinical Trials: When Diversity Priorities Show
Beyond the critical need for securing more study volunteers across the board in clinical trials, a popular concern in all areas of clinical research is achieving inclusion in clinical trials and promoting diversity. Whether in medical journals, popular press, social media,…
Colombian Pharmaceutical Market to See Strong Four Year Growth
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.1 billion by 2020, registering a compound annual growth rate (CAGR) of 7.3%, according to research and consulting firm GlobalData. The company’s latest report states that this substantial…